Original article Seul Ki Lee1, Ji Eun Choi1, Chae Min Shin2, Mi-Na Kim3 1Division of Healthcare Technology Assessment Research, 2Division for New Health Technology Assessment, National Evidence-based Healthcare Collaborating Agency, Seoul, 3Department of Laboratory Medicine Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea Corresponding to Chae Min Shin, E-mail: blu0924@neca.re.kr Ann Clin Microbiol 2021;24(3):97-104. https://doi.org/10.5145/ACM.2021.24.3.4Received on 20 April 2021, Revised on 5 July 2021, Accepted on 19 August 2021, Published on 20 September 2021.Copyright © Korean Society of Clinical Microbiology. Abstract Background: Fecal microbiota transplantation against gut colonization using a multidrugresistant organism is a technique used to treat infections through normalizing the gut microbiota via fecal microbiota transplantation in patients with confirmed colonization by carbapenem-resistant Enterobacteriaceae (CRE) or vancomycin-resistant enterococci (VRE) based on a fecal culture test within the past one week. In this study, we aimed to determine the safety and effectiveness of this technique. Methods:

Letter to the editor Junghyeon Yun1, Jung-Hyun Byun1, Yonggeun Cho2 1Department of Laboratory Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea2Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea Correspondence to Jung-Hyun Byun, E-mail: microbyun@gmail.com Ann Clin Microbiol 2025;28(1):4. https://doi.org/10.5145/ACM.2025.28.1.4Received on 16 January 2025, Revised on 24 February 2025, Accepted on 10 March 2025, Published on 20 March 2025.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Dear Editor, The genus Cardiobacterium is a fastidious, Gram-negative rod belonging to the HACEK group (Haemophilus species excluding H. inf luenzae, Aggregatibacter, Cardiobacterium, Eikenella, and Kingella). A total of 399 cases of infective endocarditis caused by HACEK species have been reported, accounting for approximately 3% of all endocarditis cases [1]. Cardiobacterium valvarum was first identified in a patient

Review article Eun Jeong Won Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Corresponding to Eun Jeong Won, E-mail: ejwon@amc.seoul.kr Ann Clin Microbiol 2024;27(4):245-255. https://doi.org/10.5145/ACM.2024.27.4.4Received on 1 September 2024, Revised on 4 November 2024, Accepted on 14 November 2024, Published on 16 December 2024.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Candidemia is the most common healthcare-associated invasive fungal infection with high crude mortality rates. It primarily affects critically ill or severely immunocompromised patients, complicating early diagnosis and prompting the initiation of appropriate antifungal therapy. The gold standard for diagnosing candidemia is blood culture; however, the sensitivity of this test is low and requires at least two days for species identification. These limitations have led to the development of alternative diagnostic methods that are

Review article Jin-Hee Han, Eun-Taek Han Department of Medical Environmental Biology and Tropical Medicine, Kangwon National University School of Medicine, Chuncheon, Korea Corresponding to Eun-Taek Han, E-mail: ethan@kangwon.ac.kr Ann Clin Microbiol 2024;27(3):155-170. https://doi.org/10.5145/ACM.2024.27.3.2Received on 31 July 2024, Revised on 14 August 2024, Accepted on 16 August 2024, Published on 9 September 2024.Copyright © Korean Society of Clinical Microbiology.This is an Open Access article which is freely available under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/). Abstract Recent advancements in malaria diagnostics have revolutionized the detection and management of this deadly disease. From traditional microscopy to rapid diagnostic tests and currently, to cutting-edge molecular techniques, such as isothermal amplification and different types of polymerase chain reactions, significant progress has been witnessed in enhancing the sensitivity, specificity, and accessibility of diagnostic tools. These innovations have enabled rapid and more accurate detection of malarial parasites, especially in regions with limited

Original article Seon A Jo1, Sang Hyuk Ma2, Seungjun Lee3, Sunjoo Kim3,4 1Department of Laboratory Medicine, Daewoo General Hospital, Geoje, 2Department of Pediatrics, Changwon Fatima Hospital, Changwon,3Department of Laboratory Medicine, Gyeongsang National University Changwon Hospital, Changwon, 4Gyeongsang National University, Gyeongsang Institute of Health Sciences, Jinju, Korea Corresponding to Sunjoo Kim, E-mail: sjkim8239@hanmail.net Ann Clin Microbiol 2020;23(3):117-124. https://doi.org/10.5145/ACM.2020.23.3.1Received on 3 January 2020, Revised on 8 February 2020, Accepted on 19 February 2020, Published on 20 September 2020.Copyright © Korean Society of Clinical Microbiology. Abstract Background: Pharyngitis is one of the most common conditions encountered in primary health care facilities. Accurate differentiation of group A streptococcus (GAS) infection from viral infection is difficult. The STANDARD F Strep A Ag FIA (SD BIOSENSOR, Korea) is a rapid antigen detection test (RADT) that has been recently developed for diagnosing GAS pharyngitis. In this study, we evaluated the diagnostic performance of the STANDARD F Strep